Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Immunology

Genetics

Cancer

Receptor

Show all topics

DOI

10.1101/2021.04.11.439323

License

CC-BY-NC

Other Formats

PDF